7Baggers
 Oramed (ORMP) Implements Stockholder Rights Agreement  GuruFocus Mon, 17 Nov 2025 14:30:19 GMT
 Oramed Pharm Declares Dividend Amidst Takeover Defense  TipRanks Mon, 17 Nov 2025 14:22:26 GMT
 Oramed Reports Fiscal Third Quarter 2025 Financial Results  Yahoo Finance Mon, 17 Nov 2025 13:55:00 GMT
 Published on: 2025-11-14 03:25:03  newser.com Fri, 14 Nov 2025 09:25:03 GMT
 Oramed: Q3 Earnings Snapshot  New Haven Register Fri, 14 Nov 2025 07:10:57 GMT
 published on: 2025-11-13 21:24:24  newser.com Fri, 14 Nov 2025 03:24:24 GMT
 Oramed: Q3 Earnings Snapshot  San Francisco Chronicle Thu, 13 Nov 2025 23:37:39 GMT
 Published on: 2025-11-12 11:02:43  newser.com Wed, 12 Nov 2025 17:02:43 GMT
 Oramed Shares Face Critical Earnings Test  AD HOC NEWS Wed, 12 Nov 2025 06:21:04 GMT
 published on: 2025-11-11 05:10:27  newser.com Tue, 11 Nov 2025 11:10:27 GMT
 published on: 2025-11-11 03:21:36  newser.com Tue, 11 Nov 2025 09:21:36 GMT
 published on: 2025-11-10 06:20:56  newser.com Mon, 10 Nov 2025 12:20:56 GMT
 published on: 2025-11-09 14:02:14  newser.com Sun, 09 Nov 2025 20:02:14 GMT
 published on: 2025-11-06 04:05:28  newser.com Thu, 06 Nov 2025 10:05:28 GMT
 published on: 2025-11-05 01:37:57  newser.com Wed, 05 Nov 2025 07:37:57 GMT
 published on: 2025-11-05 00:37:38  newser.com Wed, 05 Nov 2025 06:37:38 GMT
 msn money  MSN Tue, 04 Nov 2025 11:50:00 GMT
 published on: 2025-11-03 08:06:45  newser.com Mon, 03 Nov 2025 14:06:45 GMT

Oramed Pharmaceuticals Inc
(NASDAQ:ORMP) 

ORMP stock logo

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, ...

Founded: 2006
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends